Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director

Catalent, Inc. (CTLT) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 8-K Quarterly results
Docs: "Catalent, Inc. Reports Third Quarter Fiscal 2023 Results"
02/07/2023 8-K Quarterly results
Docs: "BYLAWS OF CATALENT, INC.",
"Catalent, Inc. Reports Second Quarter Fiscal 2023 Results"
08/29/2022 8-K Quarterly results
Docs: "Catalent, Inc. Reports Fourth Quarter Fiscal 2022 Results"
05/03/2022 8-K Quarterly results
02/01/2022 8-K Quarterly results
Docs: "BYLAWS OF CATALENT, INC.",
"Catalent, Inc. Reports Second Quarter Fiscal 2022 Results"
11/02/2021 8-K Quarterly results
Docs: "FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CATALENT, INC.",
"BYLAWS OF CATALENT, INC.",
"Catalent, Inc. Reports First Quarter Fiscal 2022 Results"
08/30/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
11/03/2020 8-K Quarterly results
Docs: "Catalent, Inc. Reports First Quarter Fiscal 2021 Results"
08/31/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
02/03/2020 8-K Quarterly results
Docs: "Stock Purchase Agreement, among Catalent Pharma Solutions, Inc., Orgenesis Inc. and GPP-II Masthercell, LLC",
"Catalent, Inc. Reports Second Quarter Fiscal 2020 Results",
"Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform"
11/05/2019 8-K Quarterly results
Docs: "Catalent, Inc. Reports First Quarter Fiscal 2020 Results"
08/27/2019 8-K Quarterly results
Docs: "Catalent, Inc. Reports Fourth Quarter Fiscal 2019 Results"
05/07/2019 8-K Quarterly results
Docs: "Catalent, Inc. Reports Third Quarter Fiscal 2019 Results"
02/05/2019 8-K Quarterly results
11/06/2018 8-K Quarterly results, Appointed a new director
Docs: "THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CATALENT, INC. The present name of the corporation is Catalent, Inc. . The Corporation was incorporated under the name “PTS Holdings Corp.” by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on March 14, 2007, which original Certificate of Incorporation was amended and restated on August 5, 2014, and which amended and restated Certificate of Incorporation was further amended and restated on November 2, 2017. This Third Amended and Restated Certificate of Incorporation of the Corporation, which restates and integrates and also further amends the provisions of the Corporation’s Certificate of Incorporation, as amended and restated, was duly adopted in accordance with the pr...",
"BYLAWS OF CATALENT, INC.",
"CATALENT, INC. 2018 OMNIBUS INCENTIVE PLAN 1.Purpose. The purposes of the Catalent, Inc. 2018 Omnibus Incentive Plan are to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, including incentive compensation measured by reference to the value of Common Stock , thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company’s stockholders. The Plan shall serve as the successor to the 2014 Omnibus Incentive Plan . If the Company’s stockholders approve thi...",
"CATALENT, INC. 2019 EMPLOYEE STOCK PURCHASE PLAN I.PURPOSE OF THE PLAN This 2019 Employee Stock Purchase Plan is intended to promote the interests of Catalent, Inc., a Delaware corporation, by providing Eligible Employees with the opportunity to acquire a proprietary interest in the Company. The Company intends that the Plan qualify as an “employee stock purchase plan” under Code Section 423 for one or more specified offerings made under the Plan. The Company may, however, establish one or more offerings under the Plan that are not designed to comply with the requirements of Code Section 423 but are intended to comply with the tax, securities and other compliance requirements of, and obtain tax and other objectives in, the foreign jurisdictions in which those offerings are conducted in ord...",
"Catalent, Inc. Reports First Quarter Fiscal 2019 Results • Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period. • Closed the acquisition of Juniper Pharmaceuticals, a European early development Center of Excellence with dose form development and clinical manufacturing capabilities. • FY'19 financial guidance reaffirmed. Somerset, N.J. - November 6, 2018 -- Catalent, Inc. , the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the first quarter of fiscal year 2019, which ended September 30, 2018. As a reminder, the Company adopted ASC 606, the new accounting standard concerning revenue from contracts with cust..."
08/28/2018 8-K Quarterly results
Docs: "Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results"
05/01/2018 8-K Quarterly results
Docs: "Catalent, Inc. Reports Third Quarter Fiscal 2018 Results"
02/05/2018 8-K Quarterly results
Docs: "Somerset, New Jersey 08873",
"Catalent, Inc. Reports Second Quarter Fiscal 2018 Results"
11/06/2017 8-K Quarterly results
Docs: "SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"BYLAWS OF CATALENT, INC. ARTICLE I",
"Catalent, Inc. Reports First Quarter Fiscal 2018 Results"
08/28/2017 8-K Quarterly results
05/04/2017 8-K Form 8-K - Current report
02/06/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "Catalent, Inc. Reports First Quarter Fiscal Year 2017 Results"
08/29/2016 8-K Form 8-K - Current report
05/04/2016 8-K Form 8-K - Current report
02/09/2016 8-K Form 8-K - Current report
11/06/2015 8-K/A Form 8-K/A - Current report [Amend]
11/03/2015 8-K Form 8-K - Current report
09/02/2015 8-K Form 8-K - Current report
05/05/2015 8-K Form 8-K - Current report
02/11/2015 8-K Form 8-K - Current report
11/13/2014 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy